82 related articles for article (PubMed ID: 14709626)
1. Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice.
Nagar S; Remmel RP; Hebbel RP; Zimmerman CL
Drug Metab Dispos; 2004 Jan; 32(1):98-104. PubMed ID: 14709626
[TBL] [Abstract][Full Text] [Related]
2. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
[TBL] [Abstract][Full Text] [Related]
3. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
4. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
[TBL] [Abstract][Full Text] [Related]
5. Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.
Argikar UA; Remmel RP
Drug Metab Dispos; 2009 Jan; 37(1):229-36. PubMed ID: 18838507
[TBL] [Abstract][Full Text] [Related]
6. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and intestinal glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl) phthalate, in humans, dogs, rats, and mice: an in vitro analysis using microsomal fractions.
Hanioka N; Isobe T; Kinashi Y; Tanaka-Kagawa T; Jinno H
Arch Toxicol; 2016 Jul; 90(7):1651-7. PubMed ID: 26514348
[TBL] [Abstract][Full Text] [Related]
8. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver.
Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T
Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626
[TBL] [Abstract][Full Text] [Related]
9. Comparing the glucuronidation capacity of the feline liver with substrate-specific glucuronidation in dogs.
van Beusekom CD; Fink-Gremmels J; Schrickx JA
J Vet Pharmacol Ther; 2014 Feb; 37(1):18-24. PubMed ID: 23888985
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
11. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; RamÃrez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T
Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics.
Alkharfy KM; Frye RF
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(1):33-8. PubMed ID: 12052720
[TBL] [Abstract][Full Text] [Related]
15. The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide.
King C; Finley B; Franklin R
Drug Metab Dispos; 2000 Jun; 28(6):661-3. PubMed ID: 10820138
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes.
Zhu B; Bush D; Doss GA; Vincent S; Franklin RB; Xu S
Drug Metab Dispos; 2008 Feb; 36(2):331-8. PubMed ID: 17998299
[TBL] [Abstract][Full Text] [Related]
17. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
[TBL] [Abstract][Full Text] [Related]
18. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
Luo CF; Cai B; Hou N; Yuan M; Liu SM; Ji H; Xiong LG; Xiong W; Luo JD; Chen MS
Arch Toxicol; 2012 Nov; 86(11):1681-90. PubMed ID: 22648071
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
Katoh M; Matsui T; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
